Understanding Your Starter Dose Options in the UK
Mounjaro vs Wegovy UK: Key Starter Dose Differences
When comparing Mounjaro vs Wegovy UK starter doses, the fundamental difference lies in their mechanisms and starting protocols. Wegovy (semaglutide) is a GLP-1 receptor agonist that begins with a 0.25mg dose for the first four weeks, designed to help your body gradually adjust to the medication. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist with its own distinct starting regimen of 2.5mg weekly.
The starter dose phase is critical for both medications, as it establishes tolerance and reduces the likelihood of gastrointestinal side effects. Wegovy's 0.25mg starting dose represents the lowest concentration in the escalation schedule, specifically formulated to introduce your system to semaglutide's appetite-regulating effects. Your prescriber will determine which starting approach aligns best with your medical history, current medications, and weight management goals when comparing Mounjaro vs Wegovy UK options.
Pricing and Value: Mounjaro vs Wegovy UK Starter Costs
When evaluating Mounjaro vs Wegovy UK pricing for starter doses, Wegovy's 0.25mg pen is available for £79.99 at EverydayMeds using discount code FIRST40 for new customers. This covers your first four weeks of treatment during the crucial adjustment period. For those planning ahead, the Intro Duo bundle (0.25mg and 0.5mg) provides weeks 1-8 for £169.99, ensuring seamless progression without reordering.
Mounjaro starter pricing differs due to its distinct dosing schedule and pen configuration. Both medications require prescription-only access through licensed UK pharmacies like EverydayMeds (GPhC #9012878). The investment in your first month establishes the foundation for your entire weight management journey, making the starter dose selection particularly important when comparing long-term value propositions between these two prescription-only medicines.
Clinical Evidence: How Mounjaro vs Wegovy UK Perform
Clinical trials demonstrate both medications' effectiveness when used alongside reduced-calorie diets and increased physical activity. The STEP trials showed Wegovy patients achieved an average weight loss of approximately 15% at 68 weeks, while STEP 2 demonstrated around 9.6% weight reduction in patients with type 2 diabetes (Wilding et al., NEJM, 2021).
Mounjaro's SURMOUNT trials revealed its own impressive clinical outcomes, though direct head-to-head comparisons between the medications haven't been conducted in identical trial populations. When considering Mounjaro vs Wegovy UK options, both represent evidence-based approaches to weight management, with your clinical assessment determining which mechanism may be more suitable for your individual circumstances.
How Wegovy Works: The GLP-1 Starter Approach
Wegovy's 0.25mg starter dose introduces semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones. This medication works by slowing gastric emptying, which helps you feel fuller for longer periods after eating smaller portions. The GLP-1 receptors in your brain's appetite control centres receive signals that reduce food cravings and promote satiety. During the starter dose phase, you may notice gradual changes in your appetite patterns and meal satisfaction levels. The 0.25mg concentration allows your digestive system to adapt to these changes while minimising potential side effects like nausea or stomach discomfort. This careful introduction sets the stage for the complete 16-week escalation schedule that leads to the maintenance dose of 2.4mg weekly.
Ordering Your Starter Dose: The EverydayMeds Process
Beginning your Mounjaro vs Wegovy UK journey through EverydayMeds starts with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your information within 3 working days (or 24 hours with express service) to determine suitability for your chosen medication. Once approved, your starter dose ships via next-day cold-chain delivery to maintain the medication's integrity from our GPhC-registered pharmacy directly to your door. The temperature-controlled packaging ensures your Wegovy 0.25mg pen arrives in perfect condition, ready for your first injection. You'll receive detailed injection instructions, dose escalation schedules, and ongoing support throughout your treatment journey.
Storage and Practical Considerations
Wegovy offers a significant practical advantage when comparing Mounjaro vs Wegovy UK storage requirements, particularly for travel and lifestyle flexibility. Wegovy pens maintain effectiveness for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Your starter dose should be stored in the refrigerator at 2-8°C until first use, then can remain at room temperature for the duration of the 4-week treatment period. The FlexTouch pen design makes self-injection straightforward, with clear dose markings and an automatic safety mechanism. Remember that dose escalation cannot be skipped or accelerated, as the gradual increase is essential for both safety and optimal effectiveness throughout your weight management programme.
First Month Expectations: Mounjaro vs Wegovy UK Starter Experience
Your first four weeks on Wegovy's 0.25mg starter dose typically involve gradual appetite changes rather than dramatic immediate effects. Many patients report reduced food cravings and earlier satiety during meals, though individual responses vary significantly. Some may experience mild gastrointestinal effects like nausea or stomach discomfort, which usually diminish as your body adapts to the medication.
Mounjaro's starter phase follows a different timeline and experience profile due to its dual-action mechanism targeting both GIP and GLP-1 receptors. When comparing Mounjaro vs Wegovy UK starter experiences, both require patience and realistic expectations, as meaningful weight changes typically become apparent after several weeks of consistent use alongside dietary modifications and increased physical activity.
Making Your Choice: Mounjaro vs Wegovy UK Starter Decision
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which starter approach aligns best with your individual needs. Consider factors like storage convenience, injection frequency comfort, and your response to the clinical assessment when making your decision. The £79.99 Wegovy starter dose provides an accessible entry point for those beginning their weight management journey with a well-established GLP-1 treatment. Use discount codes FIRST40 for new customers or DOSE25 for returning patients to access our competitive pricing on both medications. Our clinical team remains available for ongoing support throughout your treatment, ensuring you receive comprehensive care from starter dose through maintenance phases.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
